It has been documented that the tumor cells re-engineer their bone environment, favoring osteoclast recruitment and activation via interaction of TNFR-related protein receptor activator of NFκB (RANK) (on surface of osteoclasts)-RANK ligand (RANKL) (produced by osteoblasts and T and B cells). This evidence concerns the gene TNFRSF11A and neoplasm.